Thermo-Fisher Scientific Inc. (TMO) shares have a $670 price target

　　Thermo-Fisher Scientific produces analytical instruments and provides laboratory services for life sciences, pharmaceutical and industrial applications. Hardy says the life sciences tools and services industry will continue to improve throughout 2025, creating positive tailwinds for its largest company, Thermo-Fisher. He says the company benefits from its large manufacturing network and exposure to biologic-based medicine and other high-growth markets. Hardy says Thermo-Fisher's track record of innovation and its potential acquisition opportunities suggest its long-term target of 7% to 9% annual organic sales growth is within reach. CFRA has a "buy" rating and $670 price target for TMO stock, which closed at $534.42 on Dec. 3.